bioAffinity Technologies Inc. Warrant (BIAFW NASDAQ) stock market data APIs
$0.1295
0(0%)
as of June 30, 2025
Try our APIs with
free plan!
bioAffinity Technologies Inc. Warrant Financial Data Overview
Price chart is built with
Anychart
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. It operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.
Prev. Close
0.1295
Open
0.1295
High
0.1295
Low
0.1295
52 wk Range
0.102-2.9
Market Cap
0
Revenue
8 809 K
Beta
2.557
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get bioAffinity Technologies Inc. Warrant data using free add-ons & libraries
Get bioAffinity Technologies Inc. Warrant Fundamental Data
bioAffinity Technologies Inc. Warrant Fundamental data includes:
- Net Revenue: 8 809 K
- EBITDA: -9 024 766
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
Get bioAffinity Technologies Inc. Warrant End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
bioAffinity Technologies Inc. Warrant News
New
BIAF Stock Rises Post Q1 Earnings Despite Revenue Decline
Shares of bioAffinity Technologies, Inc. BIAF have risen 0.04% since the company reported its earnings for the quarter ended March 31, 2025, slightly lagging the broader market, as the S&P 500 Index r...
BioAffinity Technologies announces pricing of $3.25M offering
WallachBeth Capital announced that bioAffinity Technologies (BIAF) priced a best efforts offering of securities for aggregate gross proceeds to the company of $3.25M, before deducting agent fees and o...
The Zacks Analyst Blog Highlights Alphabet, Berkshire Hathaway, Visa and bioAffinity Technologies
For Immediate Release Chicago, IL – May 6, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and eve...
Top Stock Reports for Alphabet, Berkshire Hathaway & Visa
Monday, May 5, 2025 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
